메뉴 건너뛰기




Volumn 24, Issue 4, 2008, Pages 377-382

Effects of topical nepafenac on corneal epithelial healing time and postoperative pain after PRK: A bilateral, prospective, randomized, masked trial

Author keywords

[No Author keywords available]

Indexed keywords

BION TEARS; DIPHENHYDRAMINE; FLUOROMETHOLONE; MOXIFLOXACIN; NEPAFENAC; PLACEBO;

EID: 42149163819     PISSN: 1081597X     EISSN: None     Source Type: Journal    
DOI: 10.3928/1081597x-20080401-11     Document Type: Article
Times cited : (35)

References (19)
  • 1
    • 0038266371 scopus 로고    scopus 로고
    • LASIK vs LASER vs PRK: Advantages and indications
    • Ambrosio R Jr, Wilson S. LASIK vs LASER vs PRK: advantages and indications. Semin Ophthalmol. 2003;18:2-10.
    • (2003) Semin Ophthalmol , vol.18 , pp. 2-10
    • Ambrosio Jr, R.1    Wilson, S.2
  • 2
    • 0031660379 scopus 로고    scopus 로고
    • Surgical correction of moderate myopia: Which method should you choose? II. PRK and LASIK are the treatments of choice
    • Steinert RF, Bafna S. Surgical correction of moderate myopia: which method should you choose? II. PRK and LASIK are the treatments of choice. Surv Ophthalmol. 1998;43:157-179.
    • (1998) Surv Ophthalmol , vol.43 , pp. 157-179
    • Steinert, R.F.1    Bafna, S.2
  • 3
    • 42149106704 scopus 로고    scopus 로고
    • Reilly CD. State of refractive surgery in the U.S. Air Force. Lecture presented at the: International Military Refractive Surgery Summit; February 5, 2007; San Antonio, Tex.
    • Reilly CD. State of refractive surgery in the U.S. Air Force. Lecture presented at the: International Military Refractive Surgery Summit; February 5, 2007; San Antonio, Tex.
  • 4
    • 0031945387 scopus 로고    scopus 로고
    • A prospective randomized trial of topical soluble 0.1% indomethacin versus 0.1% diclofenac versus placebo for the control of pain following excimer laser photorefractive keratectomy
    • Assouline M, Renard G, Arne JL, David T, Lasmolles C, Malecaze F, Pouliquen YJ. A prospective randomized trial of topical soluble 0.1% indomethacin versus 0.1% diclofenac versus placebo for the control of pain following excimer laser photorefractive keratectomy. Ophthalmic Surg Lasers. 1998;29:365-374.
    • (1998) Ophthalmic Surg Lasers , vol.29 , pp. 365-374
    • Assouline, M.1    Renard, G.2    Arne, J.L.3    David, T.4    Lasmolles, C.5    Malecaze, F.6    Pouliquen, Y.J.7
  • 5
    • 0029866935 scopus 로고    scopus 로고
    • Assessment of subjective pain following photorefractive keratectomy. Melbourne Excimer Laser Group
    • McCarty CA, Garrett SK, Aldred GF, Taylor HR. Assessment of subjective pain following photorefractive keratectomy. Melbourne Excimer Laser Group. J Refract Surg. 1996;12:365-369.
    • (1996) J Refract Surg , vol.12 , pp. 365-369
    • McCarty, C.A.1    Garrett, S.K.2    Aldred, G.F.3    Taylor, H.R.4
  • 7
    • 0031788203 scopus 로고    scopus 로고
    • Comparative study of the analgesic efficacy of flurbiprofen and diclofenac in patients following excimer laser photorefractive keratectomy
    • Appiotti A, Gualdi L, Alberti M, Gualdi M. Comparative study of the analgesic efficacy of flurbiprofen and diclofenac in patients following excimer laser photorefractive keratectomy. Clin Ther. 1998;20:913-920.
    • (1998) Clin Ther , vol.20 , pp. 913-920
    • Appiotti, A.1    Gualdi, L.2    Alberti, M.3    Gualdi, M.4
  • 9
    • 0028287954 scopus 로고
    • Effect of topical diclofenac solution on discomfort after radial keratectomy
    • Epstein RL, Laurence EP. Effect of topical diclofenac solution on discomfort after radial keratectomy. J Cataract Refract Surg. 1994;20:378-380.
    • (1994) J Cataract Refract Surg , vol.20 , pp. 378-380
    • Epstein, R.L.1    Laurence, E.P.2
  • 10
    • 0030927949 scopus 로고    scopus 로고
    • Evaluation of diclofenac sodium 0.1% ophthalmic solution in the treatment of ocular symptoms after bilateral radial keratotomy
    • Hettinger ME, Gill DJ, Robin JB, Levy RH, Koester J. Evaluation of diclofenac sodium 0.1% ophthalmic solution in the treatment of ocular symptoms after bilateral radial keratotomy. Cornea. 1997;16:406-413.
    • (1997) Cornea , vol.16 , pp. 406-413
    • Hettinger, M.E.1    Gill, D.J.2    Robin, J.B.3    Levy, R.H.4    Koester, J.5
  • 11
    • 0032756335 scopus 로고    scopus 로고
    • Analgesic efficacy and safety of ketorolac after photorefractive keratectomy. Ketorolac Study Group
    • Rajpal RK, Cooperman BB. Analgesic efficacy and safety of ketorolac after photorefractive keratectomy. Ketorolac Study Group. J Refract Surg. 1999;15:661-667.
    • (1999) J Refract Surg , vol.15 , pp. 661-667
    • Rajpal, R.K.1    Cooperman, B.B.2
  • 12
    • 12644269631 scopus 로고    scopus 로고
    • Diclofenac and ketorolac in the treatment of pain after photorefractive keratectomy
    • Weinstock VM, Weinstock DJ, Weinstock SJ. Diclofenac and ketorolac in the treatment of pain after photorefractive keratectomy. J Refract Surg. 1996;12:792-794.
    • (1996) J Refract Surg , vol.12 , pp. 792-794
    • Weinstock, V.M.1    Weinstock, D.J.2    Weinstock, S.J.3
  • 13
    • 0033919218 scopus 로고    scopus 로고
    • A randomized, double-masked, clinical study of the efficacy of four nonsteroidal anti-inflammatory drugs in pain control after excimer laser photorefractive keratectomy
    • Vetrugno M, Maino A, Quaranta GM, Cardia L. A randomized, double-masked, clinical study of the efficacy of four nonsteroidal anti-inflammatory drugs in pain control after excimer laser photorefractive keratectomy. Clin Ther. 2000;22:719-731.
    • (2000) Clin Ther , vol.22 , pp. 719-731
    • Vetrugno, M.1    Maino, A.2    Quaranta, G.M.3    Cardia, L.4
  • 15
    • 0034041303 scopus 로고    scopus 로고
    • Ke TL, Graff G, Spellman JM, Yanni JM. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation, II: in vitro bioactivation and permeation of external ocular barriers. Inflammation. 2000;24:371-384.
    • Ke TL, Graff G, Spellman JM, Yanni JM. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation, II: in vitro bioactivation and permeation of external ocular barriers. Inflammation. 2000;24:371-384.
  • 16
    • 33646894688 scopus 로고    scopus 로고
    • Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: A phase II, randomized, double-masked trial
    • Colin J, Paquette B. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial. Clin Ther. 2006;28:527-536.
    • (2006) Clin Ther , vol.28 , pp. 527-536
    • Colin, J.1    Paquette, B.2
  • 18
    • 33644836124 scopus 로고    scopus 로고
    • Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK
    • Mian SI, Gupta A, Pineda R II. Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK. Cornea. 2006;25:232-234.
    • (2006) Cornea , vol.25 , pp. 232-234
    • Mian, S.I.1    Gupta, A.2    Pineda II, R.3
  • 19
    • 22744455811 scopus 로고    scopus 로고
    • Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care
    • O'Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin. 2005;21:1131-1137.
    • (2005) Curr Med Res Opin , vol.21 , pp. 1131-1137
    • O'Brien, T.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.